BEGIN:VCALENDAR
VERSION:2.0
CALSCALE:GREGORIAN
PRODID:iCalendar-Ruby
BEGIN:VEVENT
CATEGORIES:Research & Academia
DESCRIPTION:A Roundtable Discussion with Jennifer Doudna\, Stephen Hauser &
  Ehud Isacoff\n\nOver the past decade\, neuroscientists have made tremendou
 s breakthroughs in understanding the underlying causes of brain disease. At
  the same time\, CRISPR genome editing has generated new hope for developin
 g treatments for a wide range of unaddressed genetic diseases. Now a group 
 of leading researchers at UC Berkeley\, UCSF\, and the Innovative Genomics 
 Institute\, are bringing these two advancements together to create new\, br
 eakthrough therapies for neurological diseases.\n\nIn this roundtable discu
 ssion\, Jennifer Doudna\, Stephen Hauser\, and Ehud Isacoff will discuss th
 e promise and challenges of creating new therapies for neurological disease
 s and bringing them to the clinic\, as well as the need to develop cures th
 at are accessible and affordable.\n\nRead more about the recently announced
  Alliance for Therapies in Neuroscience (ATN)\, a long-term research partne
 rship with Genentech and its parent company\, Roche Holding AG\, to speed t
 he development of new therapeutics for debilitating brain diseases and diso
 rders of the central nervous system.
DTEND:20210315T230000Z
DTSTAMP:20260419T145945Z
DTSTART:20210315T220000Z
LOCATION:
SEQUENCE:0
SUMMARY:CRISPR Breakthroughs for Neurological Disease
UID:tag:localist.com\,2008:EventInstance_36158781007329
URL:https://calendar.ucsf.edu/event/crispr_breakthroughs_for_neurological_d
 isease
END:VEVENT
END:VCALENDAR